SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-053089
Filing Date
2024-04-26
Accepted
2024-04-26 17:14:15
Documents
4
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242951-1_def14a.htm DEF 14A 929094
2 GRAPHIC px_24maxcytepage01-bw.jpg GRAPHIC 218971
3 GRAPHIC px_24maxcytepage02-4c.jpg GRAPHIC 157599
4 GRAPHIC sg_davidsandoval-bw.jpg GRAPHIC 13875
  Complete submission text file 0001104659-24-053089.txt   1410350
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

IRS No.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40674 | Film No.: 24885228
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)